Kenneth R. Possenriede
CIK: 0001524478
Associated companies
Transaction History
| RKLB | ▲ Buy | Grant | 2,482 | $0 | 5/20/2026 | View on chart |
| RKLB | ▲ Buy | Grant | 3,960 | $0 | 8/27/2025 | View on chart |
| RKLB | ▲ Buy | Grant | 23,421 | $0 | 9/19/2024 | View on chart |
| RKLB | ▲ Buy | Grant | 66,797 | $0 | 8/21/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Rocket Lab shares fall after Neutron rocket delay and target cut
Rocket Lab announced a delay to its Neutron launch vehicle, citing technical issues. Following the announcement, Citizens Research cut its price target to $90, noting the delay’s impact on launch revenue in fiscal years 2027 and 2028. The news coincided with a roughly 6% drop in the stock price, as reported by multiple outlets. Analysts continue to show a wide range of price expectations, with an average target of about $103.
Rocket Lab shares fall after Neutron rocket delay and target cut. Rocket Lab announced a delay to its Neutron launch vehicle, citing technical issues. Following the announcement, Citizens Research cut its price target to $90, noting the delay’s impact on launch revenue in fiscal years 2027 and 2028. The news coincided with a roughly 6% drop in the stock price, as reported by multiple outlets. Analysts continue to show a wide range of price expectations, with an average target of about $103.